Catalyst Wire Dossier Catalyst Wire Dossier

Ipamorelin

ipamorelin · Helsinn Therapeutics (U.S.), Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ipamorelin, covering 2017-04-13 to 2017-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus [Phase 2]

See pricing